These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8585751)

  • 1. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.
    Lemozy J; Sirot D; Chanal C; Huc C; Labia R; Dabernat H; Sirot J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2580-2. PubMed ID: 8585751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.
    Stapleton P; Wu PJ; King A; Shannon K; French G; Phillips I
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2478-83. PubMed ID: 8585729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced susceptibility to co-amoxiclav in Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae isolated in Romania between 1985 and 1993.
    Espinasse F; Gheorghiu R; Poiata A; Labia R; Nicolas-Chanoine MH
    J Antimicrob Chemother; 1997 Jan; 39(1):103-6. PubMed ID: 9044036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.
    Pitout JD; Thomson KS; Hanson ND; Ehrhardt AF; Moland ES; Sanders CC
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1350-4. PubMed ID: 9624474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group.
    Chardon H; Farzaneh S; Labia R; Jarlier V; Nicolas MH; Paul G; Poyart C; Sirot D; Sirot J
    J Antimicrob Chemother; 1995 Jul; 36(1):267-9. PubMed ID: 8537279
    [No Abstract]   [Full Text] [Related]  

  • 6. Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France.
    Henquell C; Sirot D; Chanal C; De Champs C; Chatron P; Lafeuille B; Texier P; Sirot J; Cluzel R
    J Antimicrob Chemother; 1994 Nov; 34(5):707-14. PubMed ID: 7706166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.
    Tzouvelekis LS; Tzelepi E; Mentis AF; Tsakris A
    J Antimicrob Chemother; 1993 May; 31(5):645-54. PubMed ID: 8335495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli.
    Henquell C; Chanal C; Sirot D; Labia R; Sirot J
    Antimicrob Agents Chemother; 1995 Feb; 39(2):427-30. PubMed ID: 7726509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States.
    Kaye KS; Gold HS; Schwaber MJ; Venkataraman L; Qi Y; De Girolami PC; Samore MH; Anderson G; Rasheed JK; Tenover FC
    Antimicrob Agents Chemother; 2004 May; 48(5):1520-5. PubMed ID: 15105100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
    Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae.
    Jackson RT; Harris LF; Alford RH
    Antimicrob Agents Chemother; 1978 Jul; 14(1):118-25. PubMed ID: 356723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
    Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
    Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri.
    Yang Y; Bhachech N; Bradford PA; Jett BD; Sahm DF; Bush K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1671-6. PubMed ID: 9661002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244.
    Bret L; Chaibi EB; Chanal-Claris C; Sirot D; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2547-9. PubMed ID: 9371365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
    Zhou XY; Bordon F; Sirot D; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 1994 May; 38(5):1085-9. PubMed ID: 8067742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ; Amyes SG
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.
    Bradford PA; Cherubin CE; Idemyor V; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1994 Apr; 38(4):761-6. PubMed ID: 8031043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae].
    Wang QT; Liu YM; Wang H; Sun HL; Chen MJ; Du XL
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):487-90. PubMed ID: 15312399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.
    Sirot D; Chanal C; Henquell C; Labia R; Sirot J; Cluzel R
    J Antimicrob Chemother; 1994 Jun; 33(6):1117-26. PubMed ID: 7928805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.